Global Diabetes Care Devices Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight
The diabetes care devices market is largely propelled by the increasing global incidence of diabetes, which is influenced by higher obesity rates, sedentary habits, and an aging population. Heightened awareness of the benefits of early diagnosis and continuous glucose monitoring is driving the adoption of advanced solutions such as continuous glucose monitors (CGMs), insulin pumps, and smart insulin pens. Additionally, technological innovations, such as digital connectivity, AI integration, and wearable devices, are enhancing patient convenience and the precision of diabetes management.
LAS VEGAS, March 17, 2026 /PRNewswire/ -- DelveInsight's Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies' market shares, challenges, diabetes care devices market drivers, barriers, trends, and key diabetes care devices companies in the market.
Diabetes Care Devices Market Summary
To read more about the latest highlights related to the diabetes care devices market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/diabetes-care-devices-market
Key Factors Contributing to the Rise in Growth of the Diabetes Care Devices Market
Regional Diabetes Care Devices Market Insights
North America
Europe
Asia-Pacific
Get a sneak peek at the diabetes care devices market dynamics @ Diabetes Care Devices Market Trends
Recent Developmental Activities in the Diabetes Care Devices Market
What are Diabetes Care Devices?
Diabetes care devices are specialized tools and technologies designed to help individuals monitor, manage, and control their blood glucose levels effectively. These devices include blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, and smart pens, each serving a specific role in diabetes management. Blood glucose meters provide rapid snapshots of blood glucose levels, whereas CGMs offer real-time, continuous monitoring, alerting users to high or low levels. Insulin delivery devices, such as pumps and smart pens, enable precise administration of insulin according to individual needs. Together, these devices empower patients to maintain better glycemic control, reduce the risk of complications, and support a healthier, more independent lifestyle.
Diabetes Care Devices Market Report Metrics
Details
Coverage
Global
Study Period
2023–2034
Diabetes Care Devices Market CAGR
~7%
Diabetes Care Devices Market Size by 2034
~USD 76 Billion
Key Diabetes Care Devices Companies
Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi, Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, and others
Diabetes Care Devices Market Assessment
Which MedTech key players in the diabetes care devices market are set to emerge as the trendsetter explore @ Diabetes Care Devices Market Analysis
Table of Contents
1
Diabetes Care Devices Market Report Introduction
2
Diabetes Care Devices Market Executive Summary
3
Diabetes Care Devices Market Key Factors Analysis
4
Impact Analysis
5
Regulatory Analysis
6
Diabetes Care Devices Market Porter's Five Forces Analysis
7
Diabetes Care Devices Market Assessment
8
Competitive Landscape
9
Startup Funding & Investment Trends
10
Diabetes Care Devices Market Company and Product Profiles
11
KOL Views
12
Project Approach
13
About DelveInsight
14
Disclaimer & Contact Us
Interested in knowing the diabetes care devices market share by 2034? Click to get a snapshot of the Diabetes Care Devices Market Size
Related Reports
Blood Glucose Monitoring Devices Market
Blood Glucose Monitoring Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key blood glucose monitoring devices companies, including Medtronic, Abbott, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., Menarini Diagnostics s.r.l., Bionime Corporation., Nemaura, and others.
Insulin Infusion Pumps Market
Insulin Infusion Pumps Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin infusion pumps companies, including F. Hoffmann-La Roche Ltd, Medtronic, Medtrum Technologies Inc., A. Menarini Diagnostic's s.r.l., IA Collaborative Holdings, LLC, Apex Medical, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Ypsomed AG, Tandem Diabetes Care, Inc., ICU Medical, Inc., SOOIL Developments Co., Ltd., MicroPort Scientific Corporation, Microtec Medical, and others.
Insulin Pens Market
Insulin Pens Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin pens companies, including Novo Nordisk A/S, Owen Mumford Ltd, Sanofi Diabetes, Merck Sharp & Dohme Corp., Insulet Corporation., Biocon Ltd., B. Braun Melsungen AG, Eli Lilly and Co., DIABETIC PROMOTIONS., Ypsomed Logo, Medtronic., BERLIN-CHEMIE AG, pendiq., Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd., delfu-medical, Diamesco Co. Ltd. e, Becton, Dickinson and Company., Vansea Medical, Montmédand, and others.
Smart Insulin Pens Market
Smart Insulin Pens Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key smart insulin pens companies, including Emperra GmbH E-Health Technologies, Jiangsu Deflu Medical Device Co. Ltd., Medtronic, Novo Nordisk A/S, Pendiq., Sanofi, Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Ypsomed, Dexcom, Inc., and others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
[email protected]
+14699457679
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
SOURCE DelveInsight Business Research, LLP